Select Medical Holdings (SEM) Net Income towards Common Stockholders (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Net Income towards Common Stockholders data on file, last reported at $63.8 million in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $63.8 million, up 120.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$893.2 million (down 73.97% YoY), and the FY2025 annual result was -$311.3 million, down 98.3% from the prior year.
• Net Income towards Common Stockholders grew to $63.8 million in Q1 2026 per SEM's latest filing, from -$311.3 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $66.3 million in Q2 2022 and troughed at -$376.4 million in Q4 2022.
• A 5-year average of -$95.7 million and a median of $39.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders sank 910.12% in 2025, then jumped 120.08% in 2026.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$376.4 million in 2022, then jumped by 39.46% to -$227.9 million in 2023, then retreated by 27.86% to -$291.4 million in 2024, then fell by 6.86% to -$311.3 million in 2025, then soared by 120.48% to $63.8 million in 2026.
• Business Quant data shows SEM's Net Income towards Common Stockholders at $63.8 million in Q1 2026, -$311.3 million in Q4 2025, and -$321.9 million in Q3 2025.